Around 9% of adults in the United States (65 and older) have reportedly used GLP-1s like Ozempic and Wegovy. As more people have used these medications, it has transformed the conversation around obesity. They’ve helped many people lose a significant amount of weight. Additionally, they have become increasingly common among older adults seeking better health outcomes. However, emerging research suggests that rapid weight loss and changes in body composition associated with GLP-1 medications may have unintended effects on bone health. Aging already increases the risk of osteoporosis, fractures, and loss of muscle mass, so many people are wondering about the impact of GLP-1s on overall bone health. Here’s what older adults should ask their doctors before starting one.
Weight Loss Itself Can Affect Bone Density
Weight loss itself can influence bone health. Research has shown that significant weight loss may lead to reductions in bone mineral density, particularly in older adults. When body weight decreases, bones experience less mechanical loading, which can contribute to bone loss over time. Some researchers believe that part of the concern surrounding GLP-1 drugs may be related to the rapid weight reduction they often produce rather than the medication alone.
On top of that, older adults are more prone to bone issues. According to the National Institute on Aging, older adults face increased risks of osteoporosis and fractures due to age-related changes in bone remodeling. Women after menopause are particularly vulnerable, although men are not immune to bone loss. Adding substantial weight loss to an already elevated risk profile may create additional concerns for some seniors.
That said, bone density testing may be worth discussing with your doctor. If you’re considering or currently taking a GLP-1 medication, a DEXA scan can provide valuable information about bone mineral density and fracture risk. You can also discuss the option of follow-up scans, which can sometimes identify changes that warrant additional intervention.
Muscle Loss May Matter as Much as Bone Loss
Research involving GLP-1 medications often focuses on weight reduction, but not all weight loss comes from body fat. Studies from the Cleveland Clinic found that a portion of lost weight may include lean muscle mass. For older adults, maintaining muscle strength is critical because muscle helps support balance, mobility, and fall prevention. Falls remain one of the leading causes of serious injuries among seniors, making muscle preservation especially important. Asking your doctor how to protect both muscle and bone health while losing weight can be just as important as discussing the medication itself.
Nutrition Plays a Major Role in Protection
While GLP-1s may have an impact on your bone health, your overall diet and nutrition also play a role. Adequate calcium intake, sufficient vitamin D levels, and proper protein consumption all contribute to maintaining healthy bones and muscles. Older adults who lose weight rapidly may unintentionally consume fewer nutrients if they aren’t paying close attention to dietary quality. Nutrition counseling is consistently recommended as part of a comprehensive weight-loss plan.
Strength Training May Help Reduce Potential Risks
Exercise remains one of the most effective tools for preserving both bone density and muscle mass. Weight-bearing activities and resistance training encourage bones to remain strong while helping maintain functional strength. Some researchers suggest that combining GLP-1 treatment with strength training may help counteract some of the body composition changes associated with rapid weight loss. Even moderate resistance exercises can provide meaningful benefits when performed safely. Discussing an age-appropriate exercise plan with your healthcare provider may be an important part of long-term success.
The Benefits and Risks Need to Be Balanced Individually
The emerging research does not mean GLP-1 medications are unsafe or inappropriate for older adults. These drugs have demonstrated significant benefits for weight management, blood sugar control, and, in some cases, cardiovascular health. However, healthcare decisions are rarely one-size-fits-all. A senior with obesity-related health risks may reach a very different conclusion than someone who already has severe osteoporosis or multiple fracture risk factors.
Research continues to evolve, and scientists are still working to understand exactly how these medications interact with long-term bone health. A thoughtful discussion with your healthcare provider can help ensure that weight-loss goals support overall health rather than creating unintended challenges down the road.
If you take or are considering a GLP-1 weight-loss medication, what questions do you have about protecting your bone health? Share your thoughts in the comments below.
What to Read Next
GLP-1 Coverage Update: How Medicare’s New Transitional Policies Could Lower Out-of-Pocket Costs for Weight-Loss Medications
8 Weight-Loss Drugs Covered by Medicare’s New GLP-1 Bridge
Seniors Shocked by GLP-1 Prices: Does Medicare Cover Ozempic or Not?
